Allele-Specific Probe Array for Mixed Nucleic Acid Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current microarray technologies face challenges in accurately detecting genetic abnormalities in mixed nucleic acid populations, particularly in non-invasive samples like maternal blood for fetal aneuploidy and tumor DNA in cancer patients, due to low concentrations and high similarity between subpopulations, leading to high false-positive and false-negative rates.

Innovation Solution

A method using a probe array to measure copy numbers and genotypes in mixed nucleic acid samples by analyzing signals from polymorphic sites, allowing for the estimation of fetal fraction and detection of copy number variations, even at low levels, through oligonucleotide probes and detectors, enabling discrimination between major and minor subpopulations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional microarray technology is used to analyze mixed nucleic acid populations, then the analysis can be performed, but the sensitivity and specificity are insufficient leading to high false-positive and false-negative rates

Engineering Contradiction:
Improvedetection accuracyVSAvoidfalse-positive and false-negative rates
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The method segments the mixed nucleic acid population analysis into distinct genotyping and copy number analysis components. By using allele-specific probes that target specific polymorphic sites, the system can separately analyze maternal and fetal DNA signals, improving the ability to detect fetal aneuploidies without being confounded by the dominant maternal signal.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention applies local quality by using probes with specific affinities for different alleles at polymorphic sites. The probes are designed to selectively bind to specific nucleotide variants (e.g., A allele vs B allele), enabling differentiation between maternal and fetal DNA based on local sequence variations rather than requiring global differences.

Inventive Principle:
Principle #3Local quality

2Ease of operation

If non-invasive sampling methods are used to obtain nucleic acid samples, then the sampling is easier and less risky, but the concentration of target DNA is very low making detection difficult

Engineering Contradiction:
Improvesampling easeVSAvoidtarget DNA concentration
Core Design Contradiction:
Ease of operationVSQuantity of substance

Solution Approach 1:

The method changes the detection parameters by using allele-specific probes that can detect minor variations in the nucleic acid population. Instead of requiring high concentrations of target DNA, the system uses polymorphic site analysis to identify fetal DNA sequences within the mixed population, enabling detection at low fetal DNA fractions (as low as 4-15% of total cell-free DNA).

Inventive Principle:
Principle #35Parameter changes

3Device complexity

If single or low multiplex assays are used, then the assay complexity is reduced, but the ability to differentiate between aneuploid and euploid fetuses is insufficient

Engineering Contradiction:
Improveassay complexityVSAvoiddiscrimination capability
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The microarray system provides multi-functionality by simultaneously performing genotyping and copy number analysis using the same allele-specific probes. The probes can identify both the presence of specific alleles and the copy number of chromosomal regions, enabling comprehensive fetal aneuploidy detection without requiring separate assays for each function.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the sensitivity and specificity of genetic abnormality detection in non-invasive samples, reducing false-positive and false-negative rates and enabling early and accurate diagnosis of fetal aneuploidies and cancer, while minimizing the need for invasive procedures.

Implementation Method 1

conducting a first assay comprising (a) contacting the population of nucleic acid fragments with an oligonucleotide array containing a first oligonucleotide probe configured to hybridize to the target nucleic acid sequence containing the polymorphic site of the SNP

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentUS20230111097A1Array-based methods for analysing mixed samples using different allele-specific labels, in particular for detection of fetal aneuploidies
Publication Date: 2023.04.13 AFFYMETRIX INC
  • US20230111097A1 patent drawing
  • US20230111097A1 patent drawing
  • US20230111097A1 patent drawing

AI summary

Provided includes methods and systems useful in array-based analysis of mixed nucleic acid populations, including for genotyping and copy number analysis of the various subpopulations of the mixed nucleic acid population. Also provided includes methods and systems useful in the diagnosis of genetic abnormalities in a mixed nucleic acid population taken from an organism.